Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2032

Annual patent cliff calendar for 2032 — US pharmaceutical patents by expiration date.

Patents
1,150

Quick answer

1,150 indexed pharmaceutical patents have expiration dates in 2032. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8158617

    Fused heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8158658

    Heteroaromatic selective inhibitors of neuronal nitric oxide synthase

    Northwestern University · Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8158773

    RNAi modulation of RSV and therapeutic uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8158126

    Stem cell fusion model of carcinogenesis

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8158637

    Quinazolines useful as modulators of voltage gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8158146

    Stable combinations of amlodipine besylate and benazepril hydrochloride

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8158677

    Treatment of viral infections by modulation of host cell metabolic pathways

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8158659

    Dual-acting imidazole antihypertensive agents

    Theravance, Inc. · Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8158601

    Lipid formulation

    Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8158580

    Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin

    Theravance, Inc. · Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8163935

    Fused heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8163794

    Crystalline form of a 3-phenoxymethylpyrrolidine compound

    Theravance, Inc. · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8163881

    Immunoglobulin molecules with improved characteristics

    The Board of Regents of the University of Texas System · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8163893

    Pseudotyped retroviral vectors and methods of use thereof

    The Regents of the University of California · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8163920

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8163281

    Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8162918

    Gels with predetermined conductivity used in electroporation of tissue

    The Regents of the University of California · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8163309

    Starch foam microparticles

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8163509

    Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8163520

    Nucleic acids encoding a chimeric polypeptide comprising IL-7 and HGF-beta chain and methods of use

    UNIVERSITY OF CONNECTICUT · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8163297

    Live attenuated aldolase-negative bacterial vaccine

    Board of Governors for Higher Education, State of Rhode Island and Providence Plantations · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8163542

    Potent combinations of mRNA transport elements

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8165643

    Charging cradle

    CHENG UEI PRECISION INDUSTRY CO., LTD. · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8163755

    Hexahydrooxazinopterine compounds

    Takeda Pharmaceutical Company Limited · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8163707

    4′-allene-substituted nucleoside derivatives

    Enanta Pharmaceuticals, Inc. · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8163709

    TAK1-D mediated induction of cell death in human cancer cells by specific sequence short double-stranded RNAS

    The Board of Regents of the University of Texas System · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8163703

    Hepatitis C therapies

    BioCryst Pharmaceuticals, Inc. · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8163720

    Pyrrolidinyl phenyl sulphonamides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8163953

    Compounds for lysosomal modulation and methods of use

    UNIVERSITY OF CONNECTICUT · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8163711

    Compositions and methods for inhibiting expression of the HAMP gene

    Alnylam Pharmaceuticals, Inc. · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8163779

    Glucokinase activators

    Takeda San Diego, Inc. · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8163805

    Small molecule antagonists of Bcl-2 family proteins

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8163737

    CGRP receptor antagonists

    Vertex Pharmaceuticals Incorporated · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8163548

    Recombinant bicistronic flaviviruses and methods of use thereof

    The Regents of the University of California · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8163902

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8163917

    Azaindoles useful as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8163782

    1,2,4-oxadiazole benzoic acid compositions

    PTC THERAPEUTICS, INC. · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8163960

    Process for preparing and drying solid rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8163772

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxypheny1]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8163732

    Tricyclic heteroaryl compounds useful as inhibitors of Janus kinase

    Vertex Pharmaceuticals Incorporated · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8163545

    Vaccine against pandemic strains of influenza viruses

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8163294

    Growth regulatable recombinant BCG compositions

    The Regents of the University of California · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8163775

    Allosteric modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 2012100163

    SUPPRESSION OF A TYPE 1 HYPERSENSITIVITY IMMUNE RESPONSE WITH AN UNRELATED ANTIGEN

    BRIMNES JENS [DK] · Granted Thu Apr 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 2012100164

    SUPPRESSION OF A HYPERSENSITIVITY IMMUNE RESPONSE WITH UNRELATED ANTIGEN DERIVED FROM ALLERGEN SOURCE MATERIAL

    BRIMNES JENS [DK] · Granted Thu Apr 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Apr 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8168585

    Purification of peptides from colostrum

    Regen Therapeutics PLC · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8168751

    Interferon alpha mutant and its polyethylene glycol derivative

    Beijing Tri-Prime Genetic Engineering Co., Ltd · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8168678

    N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2032?

1,150 published patents in our USPTO index have expiration dates falling in calendar year 2032.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.